Moxidectin Noninferior To Ivermectin For Strongyloidiasis Treatment, Study Finds

Healio (11/29, Stulpin) reports, “Moxidectin was noninferior to ivermectin for patients with strongyloidiasis,” a study has found. The study authors “recorded a cure rate of 93.6% in the moxidectin group and 95.7% in the ivermectin group.” The study was p...